DME Capital Management, LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1489933
New York, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$97,779,678
+$10,108,522 QoQ
Shares Held
2,886,059
-0.8% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#43
of 673 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DME Capital Management, LP holds $141,822,381 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (68.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
2,886,059 | $97,779,678 | |
| 2 | VTRS |
Viatris Inc
|
2,773,470 | $44,042,703 |
All Filings in TEVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,779,678 | 2,886,059 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $87,671,156 | 2,910,729 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $95,463,088 | 3,058,734 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $76,331,295 | 3,778,777 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $63,332,302 | 3,778,777 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,733,233 | 568,200 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $10,326,841 | 468,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,853,796 | 324,850 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $5,278,812 | 324,850 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,583,632 | 324,850 | Shares | Other | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||